MORRIA

Table of contents:

Trademark domain
nameis free?
morria.com

The "MORRIA" trademark, serial number 78679127 , was filed on 26th of July 2005 with a mark drawing code of 4000 and its transaction date is 78679127. The attorney assigned is Jacqueline Zion, attorney docket number T-3711-05-US. Since 13th of April 2010, the document can be found in the L10 law office in the publication and issue section. The employee responsible is CLARKE, IDI A and the date it was published for opposition on 12/19/2006. The date when we last checked the status of this trademark was 04/12/2010.

Other trademarks by this attorney include , NUBO . The corresponded responsible for this trademark is Jacqueline Zion, located at PEARL COHEN ZEDEK LATZER LLP, 12th Floor, 1500 BROADWAY.

The state or country where the trademark was organized is by Morria Biopharmaceuticals Plc. The legal entity type behing it is a Corporation, located at 53 Davies Street, London, zip W1K5JH.

GOODS AND/OR SERVICES
International Class - 003 - Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring and abrasive preparations; soaps; perfumery, essential oils, cosmetics, hair lotions; dentifrices.
U.S. Class052 - Detergents and Soaps
Class Status6 - Active
Status Date08/01/2005
Primary Code003
International Class - 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
U.S. Class052 - Detergents and Soaps
Class Status6 - Active
Status Date08/01/2005
Primary Code005
Goods codes
GS0031Cosmetics
GS0051Pharmaceutical products and preparations for treating disease, namely, obstructive respiratory disease, asthma, inflammatory and anti-viral diseases, colitis, Crohn's disease, central nervous system insult, multiple sclerosis, contact dermatitis, psoriasis, cardiovascular disease, invasive cellular proliferative disorders, allergic rhinitis, cystic fibrosis, inflammatory disease of the skin, ophthalmologic diseases; hemolytic syndromes, sepsis, acute respiratory distress syndrome, tissue transplant rejection syndromes, autoimmune disease, viral infection, and hypersensitivity conjunctivitis; pharmaceuticals for use as a coating for cardiovascular stents and other stents; prophylactics for invasive medical procedures; anti-oxidants supplements; Pharmaceutical preparations, namely anti-inflammatories and analgesics
PROSECUTION HISTORY
DateDescriptionTypeCode
04/12/2010 ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED O - Outgoing Correspondence MAB6 - ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
04/12/2010 ABANDONMENT - NO USE STATEMENT FILED S ABN6 - ABANDONMENT - NO USE STATEMENT FILED
09/09/2009 EXTENSION 5 GRANTED S EX5G - EXTENSION 5 GRANTED
08/12/2009 EXTENSION 5 FILED S EXT5 - EXTENSION 5 FILED
09/08/2009 CASE ASSIGNED TO INTENT TO USE PARALEGAL A - Allowance for Publication AITU
08/12/2009 TEAS EXTENSION RECEIVED I - Incoming Correspondence EEXT - TEAS EXTENSION RECEIVED
03/03/2009 EXTENSION 4 GRANTED S EX4G - EXTENSION 4 GRANTED
03/03/2009 EXTENSION 4 FILED S EXT4 - EXTENSION 4 FILED
03/03/2009 TEAS EXTENSION RECEIVED I - Incoming Correspondence EEXT - TEAS EXTENSION RECEIVED
09/02/2008 EXTENSION 3 GRANTED S EX3G - EXTENSION 3 GRANTED
09/02/2008 EXTENSION 3 FILED S EXT3 - EXTENSION 3 FILED
09/02/2008 TEAS EXTENSION RECEIVED I - Incoming Correspondence EEXT - TEAS EXTENSION RECEIVED
01/31/2008 EXTENSION 2 GRANTED S EX2G - EXTENSION 2 GRANTED
01/31/2008 EXTENSION 2 FILED S EXT2 - EXTENSION 2 FILED
01/31/2008 TEAS EXTENSION RECEIVED I - Incoming Correspondence EEXT - TEAS EXTENSION RECEIVED
08/28/2007 EXTENSION 1 GRANTED S EX1G - EXTENSION 1 GRANTED
08/28/2007 EXTENSION 1 FILED S EXT1 - EXTENSION 1 FILED
08/28/2007 TEAS EXTENSION RECEIVED I - Incoming Correspondence EEXT - TEAS EXTENSION RECEIVED
03/13/2007 NOA MAILED - SOU REQUIRED FROM APPLICANT O - Outgoing Correspondence NOAM - NOTICE OF ALLOWANCE-MAILED
12/19/2006 PUBLISHED FOR OPPOSITION A - Allowance for Publication PUBO - PUBLISHED FOR OPPOSITION
11/29/2006 NOTICE OF PUBLICATION O - Outgoing Correspondence NPUB - NOTICE OF PUBLICATION
10/26/2006 LAW OFFICE PUBLICATION REVIEW COMPLETED O - Outgoing Correspondence PREV - LAW OFFICE PUBLICATION REVIEW COMPLETED
10/20/2006 ASSIGNED TO LIE A - Allowance for Publication ALIE - ASSIGNED TO LIE
10/17/2006 APPROVED FOR PUB - PRINCIPAL REGISTER P CNSA - APPROVED FOR PUB - PRINCIPAL REGISTER
10/12/2006 TEAS/EMAIL CORRESPONDENCE ENTERED I - Incoming Correspondence TEME - TEAS/EMAIL CORRESPONDENCE ENTERED
10/11/2006 CORRESPONDENCE RECEIVED IN LAW OFFICE I - Incoming Correspondence CRFA - CORRESPONDENCE RECEIVED IN LAW OFFICE
10/11/2006 TEAS RESPONSE TO OFFICE ACTION RECEIVED I - Incoming Correspondence TROA - TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/02/2006 FINAL REFUSAL MAILED O - Outgoing Correspondence CNFR - FINAL REFUSAL MAILED
05/02/2006 FINAL REFUSAL WRITTEN R - Renewal CNFR - FINAL REFUSAL WRITTEN
05/01/2006 TEAS/EMAIL CORRESPONDENCE ENTERED I - Incoming Correspondence TEME - TEAS/EMAIL CORRESPONDENCE ENTERED
04/27/2006 CORRESPONDENCE RECEIVED IN LAW OFFICE I - Incoming Correspondence CRFA - CORRESPONDENCE RECEIVED IN LAW OFFICE
04/27/2006 TEAS RESPONSE TO OFFICE ACTION RECEIVED I - Incoming Correspondence TROA - TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/27/2006 TEAS CHANGE OF CORRESPONDENCE RECEIVED I - Incoming Correspondence TCCA - TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/18/2006 NON-FINAL ACTION E-MAILED F - First Action GNRT - NON-FINAL ACTION E-MAILED
02/18/2006 NON-FINAL ACTION WRITTEN R - Renewal CNRT - NON-FINAL ACTION WRITTEN
02/13/2006 ASSIGNED TO EXAMINER D - Assigned to Examiner DOCK - ASSIGNED TO EXAMINER
08/01/2005 NEW APPLICATION ENTERED IN TRAM I - Incoming Correspondence NWAP - NEW APPLICATION ENTERED IN TRAM

The "MORRIA" trademark, serial number 77953759 , was filed on 8th of March 2010 with a mark drawing code of 4000 and its transaction date is 77953759. The attorney assigned is Jacqueline Zion, attorney docket number T-3711-05-US. Since 13th of March 2012, the document can be found in the L50 law office in the publication and issue section. The employee responsible is MILLER, DAVID S and the date it was published for opposition on 07/19/2011. The status of this trademark was checked last on 09/13/2011.

The corresponded responsible for this trademark is JACQUELINE ZION, located at PEARL COHEN ZEDEK LATZER, LLP, 1500 BROADWAY FL 12, NEW YORK, NY 10036-4068.

The state or country where the trademark was organized is by Morria Biopharmaceuticals Plc. The legal entity type behing it is a Corporation, located at Mayfair 53 Davies Street, London, zip W1K5JH.

GOODS AND/OR SERVICES
International Class - 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
U.S. Class052 - Detergents and Soaps
Class Status6 - Active
Status Date03/12/2010
Primary Code005
Goods codes
GS0051Pharmaceutical products and preparations for treating disease, namely, obstructive respiratory disease, asthma, inflammatory and anti-viral diseases, colitis, Crohn's disease, central nervous system insult, multiple sclerosis, contact dermatitis, psoriasis, cardiovascular disease, invasive cellular proliferative disorders, allergic rhinitis, cystic fibrosis, inflammatory disease of the skin, ophthalmologic diseases, hemolytic syndromes, sepsis, acute respiratory distress syndrome, tissue transplant rejection syndromes, autoimmune disease, viral infection, and hypersensitivity conjunctivitis; pharmaceuticals for use as a coating for cardiovascular stents and other stents; coating treatments, namely, pharmaceutical preparations used to coat devices for the prevention of inflammatory reactions as a result of invasive procedures; anti-oxidants supplements; pharmaceutical preparations, namely, anti-inflammatories and analgesics
PROSECUTION HISTORY
DateDescriptionTypeCode
09/13/2011 NOA E-MAILED - SOU REQUIRED FROM APPLICANT E NOAM
07/19/2011 OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED E NPUB - NOTICE OF PUBLICATION
07/19/2011 PUBLISHED FOR OPPOSITION A - Allowance for Publication PUBO - PUBLISHED FOR OPPOSITION
06/14/2011 LAW OFFICE PUBLICATION REVIEW COMPLETED O - Outgoing Correspondence PREV - LAW OFFICE PUBLICATION REVIEW COMPLETED
06/13/2011 APPROVED FOR PUB - PRINCIPAL REGISTER P CNSA - APPROVED FOR PUB - PRINCIPAL REGISTER
06/13/2011 EXAMINER'S AMENDMENT ENTERED I - Incoming Correspondence XAEC - EXAMINER'S AMENDMENT ENTERED
06/13/2011 NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED O - Outgoing Correspondence GNEN
06/13/2011 EXAMINERS AMENDMENT E-MAILED O - Outgoing Correspondence GNEA - EXAMINERS AMENDMENT E-MAILED
06/13/2011 EXAMINERS AMENDMENT -WRITTEN R - Renewal CNEA - EXAMINERS AMENDMENT -WRITTEN
01/29/2011 NOTIFICATION OF FINAL REFUSAL EMAILED O - Outgoing Correspondence GNFN
01/29/2011 FINAL REFUSAL E-MAILED O - Outgoing Correspondence GNFR - FINAL REFUSAL E-MAILED
01/29/2011 FINAL REFUSAL WRITTEN R - Renewal CNFR - FINAL REFUSAL WRITTEN
01/07/2011 TEAS/EMAIL CORRESPONDENCE ENTERED I - Incoming Correspondence TEME - TEAS/EMAIL CORRESPONDENCE ENTERED
01/07/2011 CORRESPONDENCE RECEIVED IN LAW OFFICE I - Incoming Correspondence CRFA - CORRESPONDENCE RECEIVED IN LAW OFFICE
01/07/2011 ASSIGNED TO LIE A - Allowance for Publication ALIE - ASSIGNED TO LIE
12/09/2010 TEAS RESPONSE TO OFFICE ACTION RECEIVED I - Incoming Correspondence TROA - TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/09/2010 NOTIFICATION OF NON-FINAL ACTION E-MAILED O - Outgoing Correspondence GNRN
06/09/2010 NON-FINAL ACTION E-MAILED F - First Action GNRT - NON-FINAL ACTION E-MAILED
06/09/2010 NON-FINAL ACTION WRITTEN R - Renewal CNRT - NON-FINAL ACTION WRITTEN
06/09/2010 ASSIGNED TO EXAMINER D - Assigned to Examiner DOCK - ASSIGNED TO EXAMINER
03/12/2010 NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM I - Incoming Correspondence NWOS
03/11/2010 NEW APPLICATION ENTERED IN TRAM I - Incoming Correspondence NWAP - NEW APPLICATION ENTERED IN TRAM


Information gathered on 12/31/2009. No claim is made regarding the current trademark status. This page is not to be used as legal documentation. Always consult a licensed attorney.

Based on public records. Inadvertent errors are possible.
This web site is not associated with, endorsed by, or sponsored by and has no official or unofficial affiliation with the trademark's owners.